Global Esomeprazole Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Esomeprazole Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Esomeprazole drug market in this report.
Esomeprazole report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Esomeprazole market is projected to reach US$ 212.2 million in 2029, increasing from US$ 134 million in 2022, with the CAGR of 5.6% during the period of 2024 to 2029. Demand from Gastroesophageal Reflux Disease and Duodenal Ulcers are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Esomeprazole industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Esomeprazole key manufacturers include AstraZeneca AB, Sandoz, Actavis, Teva., Mylan, KernPharm, Garmish Pharmaceuticals, Sanofi and Mepha, etc. AstraZeneca AB, Sandoz, Actavis are top 3 players and held % sales share in total in 2022.
Esomeprazole can be divided into Capsule, Tablet and Others,, etc. Capsule is the mainstream product in the market, accounting for % sales share globally in 2022.
Esomeprazole is widely used in various fields, such as Gastroesophageal Reflux Disease, Duodenal Ulcers and Others,, etc. Gastroesophageal Reflux Disease provides greatest supports to the Esomeprazole industry development. In 2022, global % sales of Esomeprazole went into Gastroesophageal Reflux Disease filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Esomeprazole market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
AstraZeneca AB
Sandoz
Actavis
Teva.
Mylan
KernPharm
Garmish Pharmaceuticals
Sanofi
Mepha
Saval Pharmaceutical
Stada
Blaskov
CQ Lummy
Segment by Type
Capsule
Tablet
Others
Gastroesophageal Reflux Disease
Duodenal Ulcers
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Esomeprazole market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Esomeprazole, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Esomeprazole industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Esomeprazole in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Esomeprazole introduction, etc. Esomeprazole Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports Conclusions of Esomeprazole market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Esomeprazole report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Esomeprazole market is projected to reach US$ 212.2 million in 2029, increasing from US$ 134 million in 2022, with the CAGR of 5.6% during the period of 2024 to 2029. Demand from Gastroesophageal Reflux Disease and Duodenal Ulcers are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Esomeprazole industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Esomeprazole key manufacturers include AstraZeneca AB, Sandoz, Actavis, Teva., Mylan, KernPharm, Garmish Pharmaceuticals, Sanofi and Mepha, etc. AstraZeneca AB, Sandoz, Actavis are top 3 players and held % sales share in total in 2022.
Esomeprazole can be divided into Capsule, Tablet and Others,, etc. Capsule is the mainstream product in the market, accounting for % sales share globally in 2022.
Esomeprazole is widely used in various fields, such as Gastroesophageal Reflux Disease, Duodenal Ulcers and Others,, etc. Gastroesophageal Reflux Disease provides greatest supports to the Esomeprazole industry development. In 2022, global % sales of Esomeprazole went into Gastroesophageal Reflux Disease filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Esomeprazole market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
AstraZeneca AB
Sandoz
Actavis
Teva.
Mylan
KernPharm
Garmish Pharmaceuticals
Sanofi
Mepha
Saval Pharmaceutical
Stada
Blaskov
CQ Lummy
Segment by Type
Capsule
Tablet
Others
Segment by Application
Gastroesophageal Reflux Disease
Duodenal Ulcers
Others
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Esomeprazole market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Esomeprazole, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Esomeprazole industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Esomeprazole in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Esomeprazole introduction, etc. Esomeprazole Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports Conclusions of Esomeprazole market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.